VIK stock news · Viking Therapeutics
Get alerts for VIK
Follow Viking Therapeutics (VIK) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for VIKBig trades happened today with 6 stocks in the Consumer Discretionary sector.
NeutralViking Therapeutics had a 10-contract call trade labeled bullish. The article reports no change to the company's business, so this trade alone does not change its outlook.
Jim Cramer advocates for purchasing the stock that has dropped 20% from its high, citing 'fantastic' reasons related to strong bookings and customer loyalty.
NeutralViking Holdings shares have fallen 20% from their peak, leading Jim Cramer to recommend the stock as a buying opportunity due to its strong bookings and customer loyalty despite recent challenges.
Complete Transcript of Viking Holdings' Earnings Call for Q2 2026 Released.
Good for VIKViking Holdings' Q2 2026 earnings report highlights a robust revenue increase and strong future bookings, which are likely to drive positive market sentiment and investor interest. Despite operational challenges, the company's optimistic outlook and fleet expansion plans suggest a solid growth trajectory.
Viking's revenue figures indicate that cruise passengers continue to spend freely.
Good for VIKViking Holdings Ltd. reported second-quarter earnings that exceeded analyst expectations, driven by increased capacity and strong demand for its cruise products. The company also noted significant growth in advance bookings for the upcoming seasons, suggesting continued consumer interest and financial health, which could positively influence its stock performance.